digital currency free, snippets

Philippine imports increased by 11.2% year-on-year in October, while exports decreased by 5.5% year-on-year.Bishuiyuan and others set up a new environmental protection technology company in Taiyuan. The enterprise search APP shows that Taiyuan Bishuiyuan Environmental Protection Technology Co., Ltd. was established recently, with the legal representative of Liu Yanwei and the registered capital of 275 million yuan. Its business scope includes: urban greening management; Water pollution prevention and control services; Sales of new membrane materials; Public utilities management services, etc. Enterprise equity penetration shows that the company is jointly held by Bishuiyuan and others.JPMorgan Chase: The cryptocurrency experienced a "milestone" month in November, and JPMorgan Chase's evaluation on the performance of cryptocurrency last month was "milestone". The agency said that Donald Trump's victory triggered a historic rebound in the encryption market. The market value in November increased by 45%, which is the best monthly return in the encryption market. In November, the US spot cryptocurrency ETF set another record. The monthly net sales of ETPs tracked by the bank in the United States set a record (about $7.6 billion).

In the first 11 months, China's foreign trade in goods reached a steady growth of 39.79 trillion yuan. The General Administration of Customs announced on the 10th that in the first 11 months of this year, the total import and export value of China's goods trade reached 39.79 trillion yuan, up 4.9% year-on-year, achieving steady growth. Among them, the export was 23.04 trillion yuan, a year-on-year increase of 6.7%; Imports reached 16.75 trillion yuan, a year-on-year increase of 2.4%.The net outflow of the main market exceeded 10 billion.Murdoch's request to modify the control of the family trust was reportedly rejected. According to people familiar with the matter, a probate commissioner in Nevada rejected a request by Rupert Murdoch to hand over the control of his media assets to his eldest son after his death, instead of dividing it equally among his four children. Murdoch, 93, had previously tried to modify a trust holding his family assets, including about 40% voting shares of Flowserve and News Corporation.

Yijing Optoelectronics invested in the establishment of a new company in Ningxia, including battery manufacturing business. According to the enterprise survey APP, Ningxia Yijing Optoelectronics Technology Co., Ltd. was recently established, with the legal representative of Liu Qiang and the registered capital of 100 million yuan. Its business scope includes: solar power generation technical services; Sales of special equipment for semiconductor devices; Manufacture of special equipment for semiconductor devices; Battery manufacturing, etc. Enterprise investigation shows that the company is wholly owned by Changzhou Yijing Optoelectronics Technology Co., Ltd., a subsidiary of Yijing Optoelectronics.Suzhou Industrial Park Phase II Industrial Investment Fund registered and established with a capital contribution of 10 billion yuan. According to Tianyancha App, Suzhou Industrial Park Phase II Industrial Investment Fund (Limited Partnership) was recently established, with Suzhou Yuanfeng Capital Management Co., Ltd. as the executive partner, with a capital contribution of 10.01 billion yuan, and its business scope covers private equity investment fund management and venture capital fund management services. According to the partner information, the fund is jointly funded by Suzhou Industrial Park State-owned Capital Investment Operation Holding Co., Ltd., Suzhou Industrial Park Economic Development Co., Ltd. and Suzhou Yuanfeng Capital Management Co., Ltd.Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.